相关实验视频
Updated: Jul 5, 2025

12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
10.5K
在pemphigus vulgaris中恢复免疫耐受性
A Razzaque Ahmed1, Mikole Kalesinskas1, Srini V Kaveri2
1Department of Dermatology, Center for Blistering Diseases, Tufts University School of Medicine, Boston, MA 02135.
概括
静脉注射免疫球蛋白 (IVIg) 治疗导致黄病 (PV) 患者的长期缓解,表明恢复了免疫平衡. 大多数患者在20年内保持无疾病状态,没有严重的不良反应.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 静脉注射免疫球蛋白 (IVIg) 是一种多克隆IgG制剂,用于治疗自身免疫性水泡性疾病,如黄 (PV).
- 尽管IVIg是有效的,但IVIg在治疗PV中的确切作用机制仍然不完全理解.
- 现有的研究已经探索了IVIg的一些抗炎和免疫调节作用.
研究的目的:
- 评估IVIg单一治疗的长期疗效和安全性,用于患者的pemphigus vulgaris.
- 调查IVIg治疗的PV患者持续免疫平衡或调节恢复的潜力.
- 建立一个人类模型来研究自身免疫病理生理学和免疫耐受机制.
主要方法:
- 这是一项长达20年的随访研究,对21名确诊PV的患者进行了随访.
- 患者接受IVIg单一治疗,遵循已公布的协议.
- 临床,血清学和免疫病理学参数在整个随访期间都受到监测.
主要成果:
- 在IVIg单一治疗中,PV患者的长期临床,血清学和免疫病理学缓解持续.
- 12名患者 (57%) 在20年内没有复发,这表明潜在的免疫恢复.
- 六名患者 (29%) 由于压力或感染等触发因素而复发,但在恢复IVIg时迅速恢复. 没有报告严重的不良反应.
结论:
- 单一的IVIg疗法可以诱导长期持续缓解的pemphigus vulgaris,可能通过恢复免疫平衡.
- 这项研究强调了IVIg在调节免疫反应和促进免疫耐受性方面的作用.
- 这项研究为了解自身免疫性疾病病理生理学和开发新的治疗策略提供了有价值的人类模型.
相关概念视频
Cell-mediated Immune Responses
68.3K
Overview
68.3K
Special Features of Adaptive Immunity
821
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
821
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K

